• Season 4 - Ep1: Extended interview on Digital solutions in arrhythmias
    Jan 22 2026

    Host: Emer Joyce

    Guest: Fleur Tjong

    Want to watch that extended interview on https://esc365.escardio.org/event/2528?resource=interview

    Go to: Want to watch that episode? Go to: https://esc365.escardio.org/event/2528

    Disclaimer:

    ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    All declarations of interest are listed at the end of the episode.

    The ESC is not liable for any translated content of this video. The English language always prevails.

    Declarations of interests:

    Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.

    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.

    Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1.

    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.

    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.

    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

    Fleur Tjong has declared to have potential conflicts of interest to report: Amsterdam UMC Innovation grant, Heath Holland TKI, Abbott, Dutch Research Council, Boston Scientific.

    Mostra di più Mostra meno
    10 min
  • Season 4 - Ep1: What´s new in TAVI? - Digital solutions in arrhythmias
    Jan 22 2026

    This episode covers:

    • Cardiology This Week: A concise summary of recent studies
    • What´s new in TAVI?
    • Digital solutions in arrhythmias
    • Mythbusters - Gratitude is heart healthy

    Host: Emer Joyce

    Guests: JP Carpenter, Davide Capodanno, Fleur Tjong

    Want to watch that episode? Go to: https://esc365.escardio.org/event/2528

    Want to watch that extended interview on Digital solutions in arrhythmias, go to: https://esc365.escardio.org/event/2528?resource=interview

    Disclaimer:

    ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    All declarations of interest are listed at the end of the episode.

    The ESC is not liable for any translated content of this video. The English language always prevails.

    Declarations of interests:

    Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.

    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.

    Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1.

    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.

    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.

    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

    Fleur Tjong has declared to have potential conflicts of interest to report: Amsterdam UMC Innovation grant, Heath Holland TKI, Abbott, Dutch Research Council, Boston Scientific.

    Mostra di più Mostra meno
    24 min
  • Season 3 - Ep.28: Extended interview on dual antiplatelet therapy (DAPT) and shortening its optimal duration
    Dec 4 2025

    Host: Emer Joyce

    Guest: Steffen Massberg

    Want to watch that extended interview on https://esc365.escardio.org/event/2178?resource=interview

    Go to: Want to watch that episode? Go to: https://esc365.escardio.org/event/2178

    Disclaimer

    ESC TV Today is supported by Bristol Myers Squibb and Novartis through an independent funding.

    The programme has not been influenced in any way by its funding partners.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    The ESC is not liable for any translated content of this video.

    The English language always prevails.

    Declarations of interests

    Emer Joyce and Steffen Massberg have declared to have no potential conflicts of interest to report.

    Mostra di più Mostra meno
    10 min
  • Season 3 - Ep.28: DAPT: how short is too short? - Obesity and atrial fibrillation
    Dec 4 2025

    This episode covers:

    • Cardiology This Week: A concise summary of recent studies
    • DAPT: how short is too short
    • Obesity and atrial fibrillation
    • Milestones: COURAGE

    Host: Emer Joyce

    Guests: Carlos Aguiar, Steffen Massberg, Prash Sanders

    Want to watch that episode? Go to: https://esc365.escardio.org/event/2178

    Want to watch that extended interview on dual antiplatelet therapy (DAPT) and shortening its optimal duration, go to: https://esc365.escardio.org/event/2178?resource=interview

    Disclaimer

    ESC TV Today is supported by Bristol Myers Squibb and Novartis through an independent funding.

    The programme has not been influenced in any way by its funding partners.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    The ESC is not liable for any translated content of this video.

    The English language always prevails.

    Declarations of interests

    Stephan Achenbach, Yasmina Bououdina, Emer Joyce, Nicolle Kraenkel and Steffen Massberg have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.

    Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo.

    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.

    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.

    Prashanthan Sanders has declared to have potential conflicts of interest to report: advisory board representative University of Adelaide, Medtronic, Boston Scientific, CathRx, Abbott and Pacemate as well as research grants for University of Adelaide: Medtronic, Abbott, Boston Scientific, Becton Dickson.

    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

    Mostra di più Mostra meno
    26 min
  • Season 3 - Ep.27: Extended interview on 'ChatGPT, MD?': large language models at the bedside
    Nov 20 2025

    Host: Emer Joyce

    Guest: Folkert Asselbergs

    Want to watch that episode? Go to: https://esc365.escardio.org/event/2179

    Want to watch that extended interview on 'ChatGPT, MD?': Large Language Models at the Bedside? Go to: https://esc365.escardio.org/event/2179?resource=interview

    Disclaimer:

    ESC TV Today is supported by Bristol Myers Squibb and Novartis through an independent funding.

    The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    The ESC is not liable for any translated content of this video. The English language always prevails.

    Declarations of interests:

    Stephan Achenbach, Folkert Asselbergs, Yasmina Bououdina, Emer Joyce, and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.

    Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo.

    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.

    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. E

    mma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson. Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

    Mostra di più Mostra meno
    10 min
  • Season 3 - Ep.27: 'ChatGPT, MD?': large language models at the bedside - Management decisions in myocarditis
    Nov 20 2025

    This episode covers:

    • Cardiology This Week: A concise summary of recent studies
    • 'ChatGPT, MD?' - Large Language Models at the Bedside
    • Management decisions in myocarditis
    • Statistics Made Easy: Mendelian randomisation

    Host: Emer Joyce

    Guests: Carlos Aguiar, Folkert Asselbergs, Massimo Imazio

    Want to watch that episode? Go to: https://esc365.escardio.org/event/2179

    Want to watch that extended interview on 'ChatGPT, MD?': Large Language Models at the Bedside? Go to: https://esc365.escardio.org/event/2179?resource=interview

    Disclaimer:

    ESC TV Today is supported by Bristol Myers Squibb and Novartis through an independent funding.

    The programme has not been influenced in any way by its funding partners.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    The ESC is not liable for any translated content of this video. The English language always prevails.

    Declarations of interests:

    Stephan Achenbach, Folkert Asselbergs, Yasmina Bououdina, Massimo Imazio, Emer Joyce, and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.

    Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo.

    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.

    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.

    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

    Mostra di più Mostra meno
    23 min
  • Season 3 - Ep.26: Extended interview on Lp(a) - What to expect in the very near future
    Nov 6 2025

    Host: Rick Grobbee

    Guest: Erik Stroes

    Want to watch that extended interview on Lp(a), go to: https://esc365.escardio.org/event/2177?resource=interview

    Want to watch that episode? Go to: https://esc365.escardio.org/event/2177

    Disclaimer:

    ESC TV Today is supported by Bristol Myers Squibb and Novartis through an independent funding.

    The programme has not been influenced in any way by its funding partners.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    The ESC is not liable for any translated content of this video. The English language always prevails.

    Declarations of interests:

    Rick Grobbee and Erik Stroes have declared to have no potential conflicts of interest to report.

    Mostra di più Mostra meno
    9 min
  • Season 3 - Ep.26: Lp(a): the future starts now - Myocardial infarction in older age and frailty
    Nov 6 2025

    This episode covers:

    Cardiology this Week: A concise summary of recent studies

    Lp(a) - What to expect in the very near future

    Myocardial infarction in older and frail adults

    Mythbusters: is beetroot good for your heart?

    Host: Rick Grobbee

    Guests: JP Carpenter, Vijay Kunadian, Erik Stroes

    Want to watch that episode? Go to: https://esc365.escardio.org/event/2177

    Want to watch that extended interview on Lp(a), go to: https://esc365.escardio.org/event/2177?resource=interview

    Disclaimer

    ESC TV Today is supported by Bristol Myers Squibb and Novartis through an independent funding.

    The programme has not been influenced in any way by its funding partners.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    The ESC is not liable for any translated content of this video.

    The English language always prevails.

    Declarations of interests

    Stephan Achenbach, Yasmina Bououdina, Rick Grobbee, Nicolle Kraenkel, Vijay Kunadian and Erik Stroes have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.

    Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo.

    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.

    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.

    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

    Mostra di più Mostra meno
    23 min